DeepMed Research

Nanfang Hospital Southern Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma

Phase 3

Conditions: Nasopharyngeal Carcinoma

Interventions: Radiation: Intensity modulated radiotherapy
Drug: Cisplatin

First Posted Date: 2017-03-03

Last Posted Date: 2017-03-03

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 716

Registration Number: NCT03068936

Effects of Limb Remote Ischemic Preconditioning for Prevention of Delirium in Elderly Patients After Non-cardiac Surgery

Not Applicable

Conditions: Elderly Patients
Non-cardiac Surgery

Interventions: Procedure: limb remote ischemic preconditioning(LRIP)

First Posted Date: 2017-01-23

Last Posted Date: 2017-01-23

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 611

Registration Number: NCT03028389

Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis

Phase 3

Conditions: Stomach Neoplasm

Interventions: Procedure: Cytoreductive surgery
Procedure: Hyperthermic Intraperitoneal Chemotherapy
Drug: Fluoropyrimidine
Drug: Cisplatin

First Posted Date: 2017-01-18

Last Posted Date: 2019-09-13

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 220

Registration Number: NCT03023436

Locations: 🇨🇳
Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, China
🇨🇳
Peking University Cancer Hospital, Beijing, Beijing, China
🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

and more 10 locations

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

Phase 3

Conditions: Peripheral T Cell Lymphoma

Interventions: Drug: chidamide
Drug: cyclophosphamide
Drug: liposomal doxorubicin
Drug: vincristine
Drug: prednisone

First Posted Date: 2017-01-18

Last Posted Date: 2017-01-18

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 174

Registration Number: NCT03023358

Locations: 🇨🇳
Ru Feng, Guangzhou, Guangdong, China

R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

Phase 3

Conditions: Lymphoma, Large B-Cell, Diffuse

Interventions: Drug: Rituximab
Drug: Etoposide
Drug: Doxorubicin
Drug: Vincristine
Drug: Cyclophosphamide
Drug: Vindesine
Drug: Bleomycin
Drug: Prednisone

First Posted Date: 2017-01-12

Last Posted Date: 2017-07-28

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 402

Registration Number: NCT03018626

Locations: 🇨🇳
Ru Feng, Guangzhou, Guangdong, China

Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Gastrectomy

Phase 2

Conditions: Stomach Neoplasms

Interventions: Procedure: ERAS

First Posted Date: 2017-01-10

Last Posted Date: 2017-01-10

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 98

Registration Number: NCT03016026

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Thalidomide Maintenance Treatment in DLBCL

Phase 3

Conditions: Lymphoma, Large B-Cell, Diffuse

Interventions: Other: Observation
Drug: Thalidomide

First Posted Date: 2017-01-10

Last Posted Date: 2017-07-28

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 226

Registration Number: NCT03016000

Locations: 🇨🇳
Ru Feng, Guangzhou, Guangdong, China

Different Surgical Procedures of Peroral Endoscopic Myotomy(POEM) for Esophageal Achalasia

Not Applicable

Conditions: Esophageal Achalasia
Esophageal Motility Disorders

Interventions: Procedure: short-myotomy
Procedure: full-thickness myotomy
Procedure: circular myotomy
Procedure: long-myotomy

First Posted Date: 2017-01-06

Last Posted Date: 2017-05-12

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 400

Registration Number: NCT03012854

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guanzhou, Guangdong, China

Multi-Center Study of Different Doses Domperidone in Feeding Intolerance

Phase 4

Completed

Conditions: Premature Birth
Domperidone Overdose
Feeding Intolerance
Gastric Retention

Interventions: Drug: normal dose
Drug: over dose
Drug: Low dose
Drug: Glucose

First Posted Date: 2016-12-02

Last Posted Date: 2017-09-15

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 118

Registration Number: NCT02980250

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

REALM China Extension Study

Conditions: Hepatitis B, Chronic

Interventions: Other: follow-up

First Posted Date: 2016-11-29

Last Posted Date: 2016-11-29

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 4000

Registration Number: NCT02974829

Locations: 🇨🇳
First Hospital of Jilin Unniversity, Changchun, Jilin, China
🇨🇳
No.6 People's hospital of Dalian, Dalian, Liaoning, China
🇨🇳
Zhongshan Hospital of Fudan University, Shanghai, China

and more 47 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy